Medical Device for Oxaliplatin-Induced Neuropathy in Gastrointestinal Cancer Patients

Summary

This is an observational study related to a medical device designed for the prevention of oxaliplatin-induced peripheral neuropathy (OIPN) in patients with gastrointestinal cancer. The primary objective is to collect data through interviews with patients experiencing OIPN symptoms to co-design the medical device prototype, incorporating the patient's perspective. Additionally, the study aims to identify clinical and usability patterns that will help optimize the design of a future clinical investigation assessing the safety and efficacy of the final device.

Eligibility

Inclusion Criteria:

* Outpatient patient with gastrointestinal cancer treated with oxaliplatin.
* Having completed at least three cycles of chemotherapy.
* Presenting acute or chronic symptoms of chemotherapy-induced peripheral neuropathy.
* The study will include individuals over 18 years old. Gender identify will be collected confidentially and inclusively, offering options for non-binary individuals and those who prefer not to identify with binary categories.

Exclusion Criteria:

* Patient with osteoarthritis or arthritis in the hands.
* Diagnosis of any autoimmune disease affecting connective tissue, such as: rheumatoid arthritis, Raynaud's syndrome, lupus, scleroderma, dermatomyositis, vasculitis, or cryoglobulinemia.

Conditions2

Browse More Trials